About Future PharmaTech
Future PharmaTech Inc., founded in 2021, focuses on neurological and vascular networks, advancing AI-powered drug discovery and nanomedicine to develop targeted therapies for dementia and erectile dysfunction (ED).
Our mission is "restoring patients' quality of life" through treatments that combine efficacy with comfort. Our Future-AI platform integrates drug repurposing and mechanism simulation to penetrate the blood-brain barrier (BBB) and improve outcomes while minimizing side effects.
Led by Dr. Ming-Wei Chao, a U.S.-certified toxicologist, we collaborate globally to shorten drug development to within five years, delivering breakthrough therapies that benefit patients worldwide.
Our Vision
Medicine can heal—or harm. At Future PharmaTech, we believe that great therapies must strike the right balance between efficacy and safety.
Traditional drug development is slow, costly, and often burdened with side effects or delayed benefits. We are changing that.
With our proprietary Future‑AI platform, we design 505(b)(2) combination therapies that merge pharmaceutical science, technology, and human-centered care—optimizing every molecule and delivery path.
Our vision is to bring innovative therapies to patients—faster, safer, and with real impact.
Future PharmaTech — The future of medicine, caring for your life.
Innovation-Driven
We challenge conventions with forward-thinking drug development.
Collaborative Culture
Cross-functional teamwork is at the heart of every solution we deliver.
Safety First
Patient safety is our foundation throughout every stage of research.
Pursuit of Excellence
We constantly optimize our process to achieve greater clinical value.
